QuidelOrtho Corporation

This committee provides the official revenue estimates and technical analysis for all tax legislation, directly influencing corporate tax structures and capital investment credits. Its work dictates the financial impact of tax policy on companies like QuidelOrtho.

This committee's control over taxation, trade, and entitlement spending (like Medicare) directly impacts QuidelOrtho. Tax policy affects corporate profitability, trade policy influences supply chain costs, and Medicare pricing is critical for reimbursement of medical devices.

This committee allocates discretionary federal spending. Its subcommittees determine the budgets for agencies like the FDA, NIH, and VA, which directly impacts their ability to fund research, regulatory operations, and procurement of medical devices from companies like QuidelOrtho.

This committee directly regulates the FDA, which is the primary regulatory body for medical devices, integral to QuidelOrtho's operations. It also influences NIH funding (research benefiting medical innovation) and labor laws affecting manufacturing costs.

This committee's oversight of antitrust laws and intellectual property (IP) is highly relevant. IP protection (patents for medical devices) is critical for manufacturers like QuidelOrtho, and antitrust decisions can impact M&A activity and market competition within the industry.

This committee directly oversees the Department of Veterans Affairs, a major healthcare provider. Its funding decisions directly impact procurement for government healthcare contractors and medical device manufacturers like QuidelOrtho that supply the VA healthcare system.